An optimal design environment for connected care software development helps bring products to their peak potential of performance and safety. Siemens Connected Care solutions can help with:
Software reliability via an embedded software platform built to the highest standards of cybersecurity, enabling connectivity and interoperability. Software compliance to enhance product quality, traceability and team coordination via application lifecycle management (ALM) tools. Software innovation to enable software designers to create connected cloud and mobile apps with a low-code platform. Siemens Connected Care helps medical device manufacturers release software more easily and efficiently with tools that improve the safety, quality and performance of connected products. The result will help launch differentiated and qualitative devices that will be adopted to improve patients’ lives. Email* …Using Linux with Medical Devices FAQ
Linux® is experiencing expansive growth in embedded devices across multiple industries. But the stringent requirements the healthcare industry imposes upon medical device certification and use requires extensive knowledge of using Linux around the issues of safety, security, and size of code.
Email* Name* First Last Company* Job Title* Address* …Connected Care: Enable smarter connected care software with built-in compliance and safety
Every day, medical device manufacturers strive to innovate and develop software systems that make devices smarter. But achieving success with connected care solutions can hit roadblocks because designers must ensure that quality issues such as bugs and cybersecurity vulnerabilities are resolved for each software release. Traces to requirements and testing must prove compliance with a variety of standards and norms. And delivery — by patient or caregiver — must be easy, intuitive, and most important safeguard against misuse.
Email* Name* First Last …These devices are the top targets of lawsuit-related advertisements
Surgical mesh products continue to drive medical device lawsuit spending. [Photo via Adobe Stock]
Spending on advertisements related to medical device lawsuits this year is on track to exceed last year’s tally.That’s according to figures provided by Washington, D.C.-based X Ante, which uses data from ad intelligence firm Vivvix. X Ante supplies reports on medical device lawsuit ad spending to the Advanced Medical Technology Association (AdvaMed), which is calling for new federal regulations of mass tort advertising to protect device manufacturers from lawsuits bankrolled by third-party funders.
For the first half of 2023, $6.2 million worth of legal ads targeted five kinds of medical devices:
Pelvic mesh: $3.5 million Hernia mesh: $1.9 million CPAP machines: $532,000 Physiomesh: $262,000 Military earplugs: $54,000Spending on the top five device categories totaled just under $11 mil…
Zeus opens Minnesota catheter manufacturing facility
A rendering of the new Zeus facility in Arden Hills, Minnesota [Image courtesy of Zeus]
Zeus has opened its catheter manufacturing facility in Arden Hills, Minnesota, celebrating the new facility with a grand opening today.
The 75,600-ft² building is home to CathX Medical, which Zeus acquired 2021. The facility has advanced R&D lab and cleanroom space for designing, developing and validating medical catheter prototypes. The facility’s capabilities include laser cutting, ablation, and welding.
Zeus said the facility will have more than 100 employees.
“Establishing a presence in Minnesota will create opportunities for innovation and partnership with our current OEM and medical device customers. It will also open doors for new relationships,” Zeus President and CEO Steve Peterson said in a news release. “As we continue expanding globally, we are honored to now be part of this medically …
Johnson & Johnson drops 136-year old logo and renames Janssen
Johnson & Johnson is replacing its iconic cursive logo with a new look. [Logos courtesy of J&J]
Johnson & Johnson has rebranded with a new logo and a new name for its Janssen pharmaceutical business one year after renaming its medical device business — and just weeks after spinning off its consumer health business.New Brunswick, New Jersey–based Johnson & Johnson (NYSE: JNJ) has replaced its 136-year-old logo — based on the signature of co-founder James Wood Johnson — with a “more modern logo and brighter red, keeping the iconic ampersand,” J&J CEO Joaquin Duato said today in a post on LinkedIn. The change is meant to call attention to J&J’s focus on innovative medicine and medtech, he said.
The Janssen Pharmaceutical Cos. of Johnson & Johnson, meanwhile, is from now on going as Johnson & Johnson Innovative Medicine, “leading where medicine is goin…
Device makers have an unexpected ally for at-home health care
Best Buy’s Geek Squad increased set-up speed in a program for remote management of chronic conditions and improved patient adherence. [Photo courtesy of Best Buy]
Who would have thought that Best Buy could help medical device developers improve patient adherence?
But that’s what the big box retailer said this week after sending specially trained Geek Squad employees to set up remote monitoring devices for patients in their homes for more than a year.
Richfield, Minnesota-based Best Buy and Danville, Pennsyvlvania-based health system Geisinger partnered on remote patient monitoring through Geisinger’s ConnectedCare365 chronic care management platform. They used Geek Squad employees to deliver the devices, activate them, and educate patients on how to use them — including troubleshooting if needed later. The Geek Squad employees were able to replace devices within 24 hours if there w…
FTC concludes antitrust investigation of $900M SAES-Resonetics nitinol deal
Nitinol is used for a variety of medtech applications. [Photo via Adobe Stock]
The Federal Trade Commission has closed its antitrust investigation into Resonetics’ planned $900 million purchase of the SAES Getters medical nitinol business.Milan, Italy-based SAES said it and Resonetics “will define the timing to finalize the closing of the transaction” in the coming days and will provide further updates.
The company did not say whether the FTC will allow the sale without conditions, but it doesn’t sound like the agency or the Department of Justice will sue over the transaction. More information was not immediately available.
Nashua, New Hampshire-based Resonetics signed a binding agreement in January 2023 to buy the medical nitinol division from SAES, including U.S. subsidiaries Memry Corp. and SAES Smart Materials. The business supplies medical device manufacturers with ra…
Freudenberg Medical launches automated hypotube coating
NEWS RELEASE: Freudenberg Medical Innovates with Advanced Hypotube Coating Automation
Read more
Freudenberg said its hypotube coating automation increases energy efficiency, reduces material waste, and enhances operator ergonomics and safety. [Photo courtesy of Freudenberg Medical]
Galway facility addresses rising medtech demand with focus on safety and environmental benefitsBEVERLY, MA ‒ September 13, 2023 ‒ Freudenberg Medical, a global CDMO for finished medical devices, components, and minimally invasive solutions, has amplified its production capacity by introducing an innovative coating process for hypotubes. By embracing automation, Freudenberg not only meets expanding customer requirements but also delivers marked improvements in operator health and safety, and environmental protection.
Cardiovascular diseases stand as the paramount cause of death globally, representing a staggering 32% of global fatalit…
ProMed Pharma marks 1-year anniversary of new development and analytical labs
ProMed Pharma’s Product Development and Analytical Testing facility in Maple Grove, Minnesota [Image courtesy of ProMed Pharma]
NEWS RELEASE: ProMed Pharma celebrates one-year anniversary of new Maple Grove development and analytical laboratoriesProMed Pharma recently celebrated the first anniversary of the opening of its Product Development and Analytical Testing facility in Maple Grove, Minnesota.
The facility currently includes two state-of-the-art Class 7 clean rooms with dedicated air handling, gowning areas and a 2,500 sq/ft analytical laboratory. The first suite is approximately 1,800 sq/ft and dedicated to supporting customer-funded early-stage development and feasibility projects using both injection molding and hot melt extrusion processes for producing sustain release products. The second suite presently houses late-stage clinical and commercial development activities using highly potent …
AdvaMed takes aim at device lawsuits funded by third parties
The Advanced Medical Technology Association (AdvaMed) is asking for new regulations to protect device manufacturers from lawsuits bankrolled by third-party funders.
Ahead of a U.S. House Committee on Oversight and Accountability hearing on the topic tomorrow, AdvaMed General Counsel and Chief Policy Officer Chris White submitted a letter in which he said “most mass tort litigation against medical device manufacturers is fueled by banks, private equity firms and hedge funds.”
AdvaMed wants new federal regulations of mass tort advertising like laws passed in Tennessee and Texas.
“The influx of billions of dollars of third-party litigation funding has fundamentally changed the dynamics of mass tort litigation,” White wrote. “These financiers are injecting huge amounts of investment capital into creating litigation regardless of the merits,” White wrote in the letter. “They start by funding mass marketing campaigns on TV, radio,…
Trelleborg will exhibit innovations in medical device components at MD&M Minneapolis
NEWS RELEASE: Trelleborg Exhibits Innovations in Medical Device Components at MD&M Minneapolis
Read more
[Image courtesy of Trelleborg]
Plymouth, Minnesota, September 2023 – Trelleborg Healthcare & Medical plans to exhibit advanced polymer solutions for healthcare and medical devices, and pharmaceutical and biotech applications, at MD&M Minneapolis in Minneapolis, Minnesota, October 10 to 11, 2023, in Booth 3202.On display are solutions offered by Trelleborg’s Innovation Center which reduce manufacturers’ time to market. Also featured are Trelleborg’s advanced capabilities in biopharmaceutical processing, thermoplastic injection molding, tubing, hose, molded parts, multicomponent and micromolding offerings.
Chris Tellers, Global Technology Director, Healthcare & Medical, says: “For healthcare and medical innovators looking to create high-performing products and measurably reduce go-to-market timel…